Skip to content
E27E27E27

Drawing based on the label description. No photo yet.

“Quinidine gluconate extended-release tablets, 324 mg are round white tablets, debossed "E27" on one side”

E27 pill

Pill with imprint E27 is white, round, 11 mm and has been identified as Quinidine Gluonate 324 mg. It is supplied by Eywa Pharma Inc.

Quinidine Gluonate 324 mg

Imprint
E27
Strength
324 mg
Color
White
Shape
Round
Size
11 mm
Score
No score line
Form
Tablet, extended release
Manufacturer
Eywa Pharma Inc
NDC
71930-016, 71930-016-12

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Quinidine Gluonate pills and guides

What is Quinidine Gluonate used for?

Official uses from the US prescribing label

Conversion of atrial fibrillation/flutter In patients with symptomatic atrial fibrillation/flutter whose symptoms are not adequately controlled by measures that reduce the rate of ventricular response, quinidine gluconate is indicated as a means of restoring normal sinus rhythm. If this use of quinidine gluconate does not restore sinus rhythm within a reasonable time (see DOSAGE AND ADMINISTRATION ), then quinidine gluconate should be discontinued. Reduction of frequency of relapse into atrial fibrillation/flutter Chronic therapy with quinidine gluconate is indicated for some patients at high risk of symptomatic atrial fibrillation/flutter, generally patients who have had previous episodes of atrial fibrillation/flutter that were so frequent and poorly tolerated as to outweigh, in the judgment of the physician and the patient, the risks of prophylactic therapy with quinidine gluconate. The increased risk of death should specifically be considered. Quinidine gluconate should be used only after alternative measures (e.g., use of other drugs to control the ventricular rate) have been found to be inadequate. In patients with histories of frequent symptomatic episodes of atrial fibrillation/flutter, the goal of therapy should be an increase in the average time between episodes. In most patients, the tachyarrhythmia will recur during therapy, and a single recurrence should not be interpreted as therapeutic failure. Suppression of ventricular arrhythmias Quinidine gluconate is also indicated for the suppression of recurrent documented ventricular arrhythmias, such as sustained ventricular tachycardia, that in the judgment of the physician are life-threatening. Because of the proarrhythmic effects of quinidine, its use with ventricular arrhythmias of lesser severity is generally not recommended, and treatment of patients with asymptomatic ventricular premature contractions should be avoided. Where possible, therapy should be guided by the results of programmed electrical stimulation and/or Holter monitoring with exercise. Antiarrhythmic drugs (including quinidine gluconate) have not been shown to enhance survival in patients with ventricular arrhythmias.

From the FDA-approved label on DailyMed (published Mar 21, 2022).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows E27 and the other side has no imprint.
  • It is white, round, 11 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Quinidine Gluconate.

Ingredients

Active: Quinidine Gluconate

Inactive: Starch, Corn, Magnesium Stearate, Cellulose, Microcrystalline, Povidone, Silicon Dioxide, Hypromellose 2208 (100 Mpa.s), Sodium Alginate

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.